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Abstract
Background: It is proposed that changes in reward processing in the
brain are involved in the pathophysiology of pain based on experimental
studies. The first aim of the present study was to investigate if reward
drive and/or reward responsiveness was altered in patients with chronic
pain (PCP) compared to controls matched for education, age and sex.
The second aim was to investigate the relationship between reward
processing and nucleus accumbens volume in PCP and controls. Nucleus
accumbens is central in reward processing and its structure has been
shown to be affected by chronic pain conditions in previous studies.
Methods: Reward drive and responsiveness were assessed with the
Behavioral Inhibition Scale/Behavioral Activation Scale, and nucleus
accumbens volumes obtained from T1-weighted brain MRIs obtained at
3T in 19 PCP of heterogeneous aetiologies and 20 age-, sex- and
education-matched healthy controls. Anhedonia was assessed with
Beck’s Depression Inventory II.
Results: The PCP group had significantly reduced scores on the reward
responsiveness, but not reward drive. There was a trend towards smaller
nucleus accumbens volume in the PCP compared to control group.
There was a significant positive partial correlation between reward
responsiveness and nucleus accumbens volume in the PCP group
adjusted for anhedonia, which was significantly different from the same
relationship in the control group.
Conclusions: Reward responsiveness is reduced in chronic pain
patients of heterogeneous aetiology, and this reduction was associated
with nucleus accumbens volume. Reduced reward responsiveness could
be a marker of chronic pain vulnerability, and may indicate reduced
opioid function.
1. Introduction
Pain and reward processing interact in the brain, and
it is proposed that changes in the function and struc-
ture of the brain’s reward network are involved in the
pathophysiology of chronic pain (Becker et al., 2012;
Denk et al., 2014). In animal models, chronic pain
alters the motivation to obtain reward (Cahill et al.,
2013; Wade et al., 2013) and leads to preference of
larger infrequent rewards (Pais-Vieira et al., 2009). In
experimental acute pain in humans, motivation to
obtain reward was shown to be increased without
affecting the self-reported hedonic response to reward
(Gandhi et al., 2013). Furthermore, an individual’s
responsiveness to reward has been demonstrated to
correlate with magnitude of analgesia during acute
experimental pain in healthy controls (Wanigasekera
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et al., 2012). Taken together, these results suggest a
role of altered motivation or drive to obtain reward
and reward responsiveness in pain, which may also be
present in patients with chronic pain (PCP). Whether
PCP have altered reward drive and/or responsiveness
remains to be ascertained. An individual’s drive to
obtain reward and hedonic response to the presence
or anticipation of reward can be measured with
Reward Drive and Reward Responsiveness, respec-
tively (Gray, 1981; Carver and White, 1994). Both
scales correlate with reward-maximizing behaviour in
healthy controls, although more strongly reward
responsiveness (Scheres and Sanfey, 2006).
In the brain, reward processing is closely linked to
the nucleus accumbens (Becerra et al., 2001; Salamone
and Correa, 2012). Ventral striatum grey matter density
has been shown to correlate with both a combination
score of personality traits that included reward drive
and reward responsiveness and degree of placebo anal-
gesia in healthy controls (Schweinhardt et al., 2009).
Furthermore, a systematic meta-analysis of brain struc-
ture in PCP demonstrated reduced volume in the area
of the nucleus accumbens (Smallwood et al., 2013),
and nucleus accumbens grey matter density has been
shown to decrease after the onset of chronic back pain
(Baliki et al., 2012). The biological mechanisms under-
lying the observed volume change are unknown, but
chronic pain induced changes in several neurotransmit-
ter systems (D’Angio et al., 1987; Li et al., 2001; Chang
et al., 2014; Schwartz et al., 2014), and connectivity
with other basal ganglia as well as cortical regions
(Mansour et al., 2013; Chang et al., 2014) may play a
role. The observed structural changes in the nucleus
accumbens may in turn be linked to the proposed
changes in reward processing in pain conditions.
To our knowledge, reward drive, reward respon-
siveness and the relationship between them and
nucleus accumbens volume have not been investi-
gated in PCP. The first aim of the present study was
to investigate if reward drive and/or reward respon-
siveness are reduced in PCP compared to controls
matched for education, age and sex. The second aim
was to investigate the relationship between reward
processing and nucleus accumbens volume in PCP
and controls. Since anhedonia is common in PCP
and interacts with both reward responsiveness (Bee-
vers and Meyer, 2002) and nucleus accumbens vol-
ume (Harvey et al., 2007; Wacker et al., 2010),
correlation analyses were corrected for anhedonia.
2. Methods
The study was approved by the Regional Committee
for Medical Research Ethics and the Norwegian
Social Sciences Data Service, and performed in
accordance with their requirements and the Declara-
tion of Helsinki. Written informed consent was
obtained from all participants.
2.1 Materials
Twenty patients (16 females) were recruited from a
university hospital pain clinic, and 20 age-, educa-
tion- and sex-matched healthy controls (HC) (18
females) from the local community. Exclusion crite-
ria were left handedness, neurological disease, psy-
chiatric disease (not including mild or moderate
depression), known traumatic brain injury and high
analgesics consumption (>180 mg codeine or equiva-
lent per 24 h, 24 h continuous benzodiazepine treat-
ment, or using carisoprodol). One PCP was excluded
during the study due to neurological disease discov-
ered after inclusion. The final sample encompassed
19 PCP (16 females) and 20 HC (18 females).
2.2 Pain
Pain was assessed with a Norwegian translation of the
Brief Pain Inventory (Cleeland, 1991). The question-
naire assesses pain intensity at present and the aver-
age pain intensity over the last 24 h using a numerical
rating scale from 1 to 10, as well as present analgesics
use. Aetiology of pain and duration of pain was calcu-
lated based on data from patient journals and classi-
fied to 1–2 years, 2–4 years, 4–6 years, 6–10 years or
10+ years by one of the authors, an experienced clini-
cian (P.C.B.).
What’s already known about this topic?
• Nucleus accumbens is involved in reward
processing.
• Reward drive and responsiveness is altered in
experimental pain.
• Chronic pain influences nucleus accumbens
volume.
What does this study add?
• Reward responsiveness is reduced in chronic
pain patients.
• Nucleus accumbens volume is positively associ-
ated with reward responsiveness in chronic
pain patients.
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2.3. Reward responsiveness
The Behavioral Inhibition Scale/Behavioral Activa-
tion Scale (BIS/BAS) was used to assess different
aspects of reward (Carver and White, 1994) based
on Gray’s reinforcement theory (Gray, 1981).
Reward drive was assessed with the Drive subscale,
which measures the self-reported tendency to pursue
reward. Reward responsiveness was assessed with
the Reward Responsiveness subscale, which mea-
sures the emotional response to the presence or
anticipation of rewards. The third BAS subscale Fun
Seeking, a measure of impulsivity and desire for
excitement linked to obtaining rewards, was not
included, as this measure has not been suggested to
be involved in pain pathology.
2.4 Anhedonia
Anhedonia was assessed with the Beck Depression
Inventory II (BDI) (Beck et al., 1996). A subscale for
anhedonia, BDI-Anhedonic, was calculated from BDI
(Leventhal et al., 2006).
2.5 Magnetic resonance imaging
Scanning was performed on a 3T Siemens Trio scan-
ner with a 12-channel Head Matrix Coil (Siemens
AG, Erlangen, Germany). Foam pads were used to
minimize head motion. One T1-weighted 3D volume
was acquired (TR = 2300 ms, TE = 2.88 ms,
TI = 900 ms, flip angle = 9°, FOV = 526, slices 160,
slice thickness = 1.2 mm, in-plane resolution of
1.0 9 1.0 mm). No morphological abnormalities
were revealed by inspection in any of the included
participants.
The T1-weighted 3D images were analysed in Neu-
roQuant (CorTechs Labs, Inc., CA, USA) to quantify
the volume of nucleus accumbens corrected for ICV
(Brewer et al., 2009). NeuroQuant is an FDA 510k-
approved fully automated morphometric method for
clinical use where segmentation of subcortical struc-
tures is atlas-based using both intensity and location
for determining structure.
2.6 Statistical analyses
Normality was tested for all variables. For variables
with a normal distribution within the group, statisti-
cal differences between the group means were tested
with two-tailed independent group Student’s t-test
(nucleus accumbens volume). For variables with a
non-normal distribution in both groups, statistical dif-
ferences between groups were tested with two-tailed
Mann–Whitney U-tests (pain measures, reward
responsiveness, drive and anhedonia). Only BAS
measures with significant group differences were
used in further analyses.
Within-group partial correlations were tested with
two-tailed Spearman’s Rho, adjusted for anhedonia.
A non-parametric test for correlation was used, since
the variables except nucleus accumbens volumes,
were not normally distributed in at least one group.
Statistical differences between the within-group cor-
relation coefficients obtained in the PCP and HC
groups, respectively, were tested with Fisher’s r-to-z
transformation (Myers and Sirois, 2006). Exact p-val-
ues are reported, and p ≤ 0.05 was considered statis-
tical significant. Effect sizes were calculated as r = Z/
√N. Due to incomplete questionnaire responses,
reward responsiveness data were excluded for two
controls and anhedonia for one control. MRI data
from four PCP were lost due to technical problems.
These subjects were excluded on an analysis by
analysis basis.
3. Results
The PCP group had significantly higher Brief Pain
Inventory scores at the time of investigation
(U = 380.0, p < 0.001, r = 0.90) and during the 24 h
prior to testing (U = 375.5, p < 0.001, r = 0.84)
(Table 1). Pain duration was from 1 to >10 years in
the PCP group (number of years of chronic pain:
number of patients; 1–2: 1, 2–4: 4, 4–6: 2, 6–10: 4,
>10: 8). Pain was widely distributed to a number of
body areas (see Fig. 1).
The majority of subjects in the PCP group reported
using analgesics (regular users of paracetamol: 11;
Table 1 Pain, Behavioral Activation Scale reward responsiveness and
drive scores in patients with chronic pain and healthy control groups.
Median
U p r
Patients with
chronic pain
Healthy
controls
Pain level
last 24 h
6.00 0.50 375.5 <0.0005* 0.84
BAS-Reward
Responsiveness
15.00 18.00 80.0 0.005* 0.46
BAS-Reward Drive 10.00 9.50 174.5 0.916 0.02
Numbers are medians within groups in chronic pain patients with pain
self-rating of ≥4 out of 10 for ≥6 months and in their matched healthy
controls. Statistical differences between groups were explored with a
two-tailed Mann–Whitney U-test. Effect size r is calculated as r = Z/√N.
BAS, Behavioral Activation Scale.
*p < 0.05.
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codeine: 9, NSAID: 8; pregabaline: 4; amitriptyline:
2; SSRI: 2) (Table 2). Twelve in the PCP group
reported using more than two types of medications.
As expected, the PCP group exhibited significantly
higher anhedonia scores than controls (U = 288.0,
p < 0.01, r = 0.56). Pain types, duration, medication
and distribution in the PCP group are described in
Table 2 and Fig. 1.
The PCP group had significantly lower reward
responsiveness scores (U = 80, p = 0.005, r = 0.46)
(Table 1). There was no difference between the PCP
and HC groups on the reward drive scores (Table 1).
A Student’s t-test revealed a trend towards smaller
nucleus accumbens volume in the PCP group com-
pared to the HC group (PCP: 0.076  0.012, con-
trols: 0.082  0.009; p = 0.062).
There was a significant positive partial correlation
between nucleus accumbens volume and reward
responsiveness scores in the PCP group when adjust-
ing for anhedonia (rho = 0.534, p = 0.049) (Table 3
and Fig. 2). There were no significant correlations
between nucleus accumbens volume, 24-h pain rat-
ing or duration of pain condition in the PCP group
(Table 3). There was no significant correlation
between nucleus accumbens volume and reward
responsiveness scores in the HC group (Table 3 and
Fig. 2). Statistical comparisons of the correlation
coefficients for reward responsiveness scores and
nucleus accumbens volumes in the PCP and HC
groups demonstrated a significantly different rela-
tionship between reward responsiveness and nucleus
accumbens volume in the two groups (Fisher r-to-z
transformation, z = 2.12 or p = 0.034).
4. Discussion and conclusion
In the present study, we showed that the PCP group
had a specific reduction in reward responsiveness
demonstrating a lower sensitivity to the occurrence
or anticipation of reward. This is the first direct evi-
dence for reduced reward responsiveness in PCP.
There was no difference in reward drive between the
PCP and HC groups.
The current finding of a specific reduction in
reward responsiveness while reward drive was at
control levels was unexpected. To our knowledge,
this has not been investigated before in chronic pain
patients, but experiments in healthy subjects have
shown that acute pain increases motivation, but does
not affect the hedonic reward response (Gandhi
et al., 2013). The present finding of normal reward
drive does not support the suggestion that chronic
pain would reduce motivation (Gandhi et al., 2013).
Rather, our finding of a significant reduction in
reward responsiveness in the PCP group demon-
strates reduced hedonic response to rewards in PCP.
Figure 1 Subjective location of pain reported by patients, in the Brief
Pain Inventory questionnaire. Red areas indicate areas where patients
felt pain, and dots indicate areas where patients felt highest levels of
pain. The colouring was made translucent to show increased intensity
in areas where more than one patient reported pain.
Table 2 Number of chronic pain patients according to pain aetiology,
pain duration and types of medication used.
Pain aetiology
Musculoskeletal 12
Visceral 5
Idiopathic 2
Neuropathic 0
Pain duration (years)
<2 1
2–4 4
4–6 2
6–10 4
>10 8
Analgesic users
Paracetamol 11
Codeine 9
NSAID 8
Pregabalin 4
Amitriptyline 2
SSRI 2
Numbers are number of patients in each class. Each patient was clas-
sified according to one aetiology. Classification was performed by an
experienced clinician (P.C.B.) based on patient records. SSRI, selective
serotonin receptor inhibitors; NSAID, non-steroidal anti-inflammatory
drugs.
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If acute pain does not affect the hedonic experience
of rewards (Gandhi et al., 2013), reduced reward
responsiveness in PCPs could be a consequence of
the long-term effects of pain or a marker of chronic
pain vulnerability (Denk et al., 2014).
The trend towards reduction in nucleus accum-
bens volume concurs with a previous study that
showed reduction in its size as pain became chronic
and in a meta-analyses of morphometric studies on
PCPs (Baliki et al., 2012; Smallwood et al., 2013).
However, one study on rheumatoid arthritis patients
found increased nucleus accumbens volume (Wart-
olowska et al., 2012). Many of the patients in the
current study were included in a previous study on
decision making where significantly smaller nucleus
accumbens volume was demonstrated in the PCP
group (Elvemo et al., 2014). This, combined with
the large effect size for nucleus accumbens volume
differences between the PCP and HC in the current
study, indicates that the current study is underpow-
ered and sensitive to type II errors. The lack of corre-
lation between nucleus accumbens volume and pain
duration could be explained by the much longer
duration of the pain conditions in the present study
than in the study by Baliki et al. (2012).
The reduction in reward responsiveness was signif-
icantly correlated with reduced nucleus accumbens
volume in PCPs, and this relationship was signifi-
cantly different from that found in the controls.
Using voxel-based morphometry, it has previously
been shown in healthy men that ventral striatum
grey matter density correlated positively with both
placebo analgesia and a combination score of person-
ality traits which included reward drive and reward
responsiveness as well as other measures (Schwein-
hardt et al., 2009). This finding differs from the
result in the healthy controls (predominantly
women) in the present study where no significant
association between reward responsiveness scores
and nucleus accumbens volumes was detected. These
contrasting results could be due to differences in
‘reward’ measures, including anhedonia scores, as
well as different image analysis approaches and sex
and age distributions. There is no straightforward
relationship between behaviour or function and
brain structure volume, but it is well known that
nucleus accumbens is important for reward process-
ing (Salamone and Correa, 2012). The significant
correlation between nucleus accumbens volume and
reward responsiveness, combined with the signifi-
cantly reduced reward responsiveness in PCP group
provide experimental support to the hypothesis that
Table 3 Partial correlations in patients with chronic pain and healthy controls.
Patients with chronic pain Healthy controls
Pain level 24 h
BAS-Reward
Responsiveness
Nucleus accumbens
volume Pain level 24 h
BAS-Reward
Responsiveness
Nucleus accumbens
volume
Pain level 24 h – –
BAS-Reward Responsiveness r = 0.006
p = 0.980
– r = 0.065
p = 0.812
–
Nucleus accumbens volume r = 0.171
p = 0.559
r = 0.534*
p = 0.049
– r = 0.238
p = 0.341
r = 0.341
p = 0.197
–
Pain duration r = 0.057
p = 0.821
r = 0.254
p = 0.309
r = 0.382
p = 0.178
– – –
Numbers are Spearman’s rho from partial correlation in patients with chronic pain and their matched healthy controls, adjusted for anhedonia
scores. Statistical differences within groups were explored with a two-tailed Spearman’s rank order correlation.
Anhedonia was measured with a subscale of the Beck Depression Inventory II that measures anhedonic state. Nucleus accumbens volume is the
combined volume of the left and right nucleus accumbens in % of intracranial volume. Duration of chronic pain was only recorded for patients with
chronic pain, not in the matched healthy controls.
*p < 0.05.
Figure 2 Nucleus accumbens volume by reward responsiveness for
patients with chronic pain (dark grey boxes) and their matched
healthy controls (light grey circles).
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PCP have altered reward processing and that nucleus
accumbens is involved in this.
It has been suggested that reward processing in
PCP might be disrupted due to changes in the dopa-
mine and/or opioid systems (Comings and Blum,
2000; Becker et al., 2012). Both increased tonic lev-
els of dopamine in the nucleus accumbens causing
reduced phasic dopamine levels thereby affect moti-
vational ‘wanting’, and reduced opioid receptor den-
sity in the nucleus accumbens disrupting hedonic
‘liking’ are possible mechanisms of altered reward
processing in PCP (Leknes and Tracey, 2008; Ber-
ridge et al., 2009). A potential interpretation of the
current results in the light of Becker and colleagues’
hypothesis is that the reduced reward responsiveness
stems from opioid system dysfunction. In support of
this interpretation are findings in healthy subjects
demonstrating that reward responsiveness is corre-
lated with magnitude of opioid analgesia and pre-
dicts neural activity in the nucleus accumbens
(Wanigasekera et al., 2012). Previous studies have
shown that PCP have abnormal opioid systems (Har-
ris et al., 2007) and in the clinic, these patients fre-
quently show reduced response to opioids
(Manchikanti et al., 2011). During chronification of
pain, changes in the opioid and dopamine systems
are accompanied by changes in neuronal activity
and connectivity in an animal models of neuropathic
pain (Chang et al., 2014), consistent with cross-sec-
tional and longitudinal studies in humans with
chronic pain (Baliki et al., 2012). These changes
may be linked to both changes in nucleus accum-
bens volume and reward processing. One may spec-
ulate that the correlation between nucleus
accumbens volume and reward responsiveness is
associated with reduced opioid response in PCP,
which in turn points to reduced reward responsive-
ness as a possible predictor of opioid response. Since
reward is linked to the dopaminergic neurotransmit-
ter system, dopamine is necessarily also a part of
this.
There was no significant correlation between
reward responsiveness and pain duration. As the
current study was not designed to investigate causal-
ity, it is not possible to conclude on the causal rela-
tionship of chronic pain and reduced reward
responsiveness. Grey’s BAS is considered to measure
a stable personality trait, and reduced reward
responsiveness may hence be present before a
chronic pain condition is established. If this is the
case, reward responsiveness assessment may be an
important factor to take into consideration in indi-
viduals at risk of developing chronic pain conditions,
such as in acute back pain. However, it would be
surprising if the neurochemical and/or neuropsycho-
logical changes present in PCPs (Apkarian et al.,
2011) does not also affect brain activity related to
BAS.
While the PCP group had heterogeneous pain aeti-
ologies that reduce the current study’s ability to find
aetiology-specific differences, the heterogeneity
increases the ecological validity and makes signifi-
cant findings more applicable to chronic pain in gen-
eral. Moreover, right and left nucleus accumbens
volumes were combined to reduce number of statis-
tical tests, and because the small PCP group had
varying degrees of lateralization of pain (see Fig. 1).
Thus, lateralization effects and specificity of nucleus
accumbens changes with regard to localization of the
chronic pain could not be investigated. Inclusion of
patients on different types of analgesics could also
have affected the results, at the benefit of increased
ecological validity. At the risk of type I errors, the
current study did not correct for multiple compari-
sons since the number of tests and subjects was low
and this would increase the risk a of type II errors.
In summary, chronic pain patients exhibited sig-
nificantly reduced reward responsiveness which was
positively associated with nucleus accumbens vol-
ume. There was no difference in reward drive
between the PCP and HC groups. Future research
should investigate if reduced reward responsiveness
is a premorbid trait of chronic pain, and if so a mar-
ker of susceptibility to chronic pain and/or an indica-
tor for treatment type and/or response.
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